skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Renal Cell Carcinoma Peptides Vaccine IMA901 (Code C70968)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Renal Cell Carcinoma Peptides Vaccine IMA901

Definition: A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901 consists of 10 different synthetic tumor-associated peptide (TUMAP) antigens (9 HLA-class I-binding and 1 HLA class II-binding); endogenously, these TUMAPs are expressed by the majority of renal cell carcinomas. Vaccination with this agent may significantly increase host cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing these peptide antigens.

Display Name: Renal Cell Carcinoma Peptides Vaccine IMA901

Label: Renal Cell Carcinoma Peptides Vaccine IMA901

NCI Thesaurus Code: C70968 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL375872  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Renal Cell Carcinoma Peptides Vaccine IMA901

External Source Codes: 
PDQ Closed Trial Search ID 570963
PDQ Open Trial Search ID 570963 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C70968
Contributing_Source CTRP
Legacy_Concept_Name Renal_Cell_Carcinoma_Peptides_Vaccine_IMA901
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom